132 related articles for article (PubMed ID: 34183450)
21. Association between HIC1 and RASSF1A promoter hypermethylation with MTHFD1 G1958A polymorphism and clinicopathological features of breast cancer in Iranian patients.
Rasti M; Tavasoli P; Monabati A; Entezam M
Iran Biomed J; 2009 Oct; 13(4):199-206. PubMed ID: 19946345
[TBL] [Abstract][Full Text] [Related]
22. MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AML.
Larmonie NSD; Arentsen-Peters TCJM; Obulkasim A; Valerio D; Sonneveld E; Danen-van Oorschot AA; de Haas V; Reinhardt D; Zimmermann M; Trka J; Baruchel A; Pieters R; van den Heuvel-Eibrink MM; Zwaan CM; Fornerod M
Oncogene; 2018 Jan; 37(1):107-115. PubMed ID: 28892045
[TBL] [Abstract][Full Text] [Related]
23. Active vitamin D induces gene-specific hypomethylation in prostate cancer cells developing vitamin D resistance.
Lai GR; Lee YF; Yan SJ; Ting HJ
Am J Physiol Cell Physiol; 2020 May; 318(5):C836-C847. PubMed ID: 32159363
[TBL] [Abstract][Full Text] [Related]
24. DLEC1, a 3p tumor suppressor, represses NF-κB signaling and is methylated in prostate cancer.
Zhang L; Zhang Q; Li L; Wang Z; Ying J; Fan Y; He Q; Lv T; Han W; Li J; Yang Y; Xu B; Wang L; Liu Q; Sun Y; Guo Y; Tao Q; Jin J
J Mol Med (Berl); 2015 Jun; 93(6):691-701. PubMed ID: 25648635
[TBL] [Abstract][Full Text] [Related]
25. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.
Koutsimpelas D; Pongsapich W; Heinrich U; Mann S; Mann WJ; Brieger J
Oncol Rep; 2012 Apr; 27(4):1135-41. PubMed ID: 22246327
[TBL] [Abstract][Full Text] [Related]
26. The RASSF1A tumor suppressor gene is inactivated in prostate tumors and suppresses growth of prostate carcinoma cells.
Kuzmin I; Gillespie JW; Protopopov A; Geil L; Dreijerink K; Yang Y; Vocke CD; Duh FM; Zabarovsky E; Minna JD; Rhim JS; Emmert-Buck MR; Linehan WM; Lerman MI
Cancer Res; 2002 Jun; 62(12):3498-502. PubMed ID: 12067994
[TBL] [Abstract][Full Text] [Related]
27. Promoter hypermethylation of RASSF1A, MGMT, and HIC-1 genes in benign and malignant colorectal tumors.
Abouzeid HE; Kassem AM; Abdel Wahab AH; El-mezayen HA; Sharad H; Abdel Rahman S
Tumour Biol; 2011 Oct; 32(5):845-52. PubMed ID: 21274674
[TBL] [Abstract][Full Text] [Related]
28. Epigenetic regulation of EFEMP1 in prostate cancer: biological relevance and clinical potential.
Almeida M; Costa VL; Costa NR; Ramalho-Carvalho J; Baptista T; Ribeiro FR; Paulo P; Teixeira MR; Oliveira J; Lothe RA; Lind GE; Henrique R; Jerónimo C
J Cell Mol Med; 2014 Nov; 18(11):2287-97. PubMed ID: 25211630
[TBL] [Abstract][Full Text] [Related]
29. Tumor suppressor gene inactivation during cadmium-induced malignant transformation of human prostate cells correlates with overexpression of de novo DNA methyltransferase.
Benbrahim-Tallaa L; Waterland RA; Dill AL; Webber MM; Waalkes MP
Environ Health Perspect; 2007 Oct; 115(10):1454-9. PubMed ID: 17938735
[TBL] [Abstract][Full Text] [Related]
30. CpG island promoter hypermethylation of Ras association domain family 1A gene contributes to gastric carcinogenesis.
Joo MK; Kim KH; Park JJ; Yoo HS; Choe J; Kim HJ; Lee BJ; Kim JS; Bak YT
Mol Med Rep; 2015 Apr; 11(4):3039-46. PubMed ID: 25483734
[TBL] [Abstract][Full Text] [Related]
31. Mahanine reverses an epigenetically silenced tumor suppressor gene RASSF1A in human prostate cancer cells.
Jagadeesh S; Sinha S; Pal BC; Bhattacharya S; Banerjee PP
Biochem Biophys Res Commun; 2007 Oct; 362(1):212-217. PubMed ID: 17698033
[TBL] [Abstract][Full Text] [Related]
32. A feedback regulation between miR-145 and DNA methyltransferase 3b in prostate cancer cell and their responses to irradiation.
Xue G; Ren Z; Chen Y; Zhu J; Du Y; Pan D; Li X; Hu B
Cancer Lett; 2015 May; 361(1):121-7. PubMed ID: 25749421
[TBL] [Abstract][Full Text] [Related]
33. Association between RASSF1A promoter methylation and prostate cancer: a systematic review and meta-analysis.
Pan J; Chen J; Zhang B; Chen X; Huang B; Zhuang J; Mo C; Qiu S
PLoS One; 2013; 8(9):e75283. PubMed ID: 24073258
[TBL] [Abstract][Full Text] [Related]
34. Histone methyltransferase KMT2D sustains prostate carcinogenesis and metastasis via epigenetically activating LIFR and KLF4.
Lv S; Ji L; Chen B; Liu S; Lei C; Liu X; Qi X; Wang Y; Lai-Han Leung E; Wang H; Zhang L; Yu X; Liu Z; Wei Q; Lu L
Oncogene; 2018 Mar; 37(10):1354-1368. PubMed ID: 29269867
[TBL] [Abstract][Full Text] [Related]
35. DNA methyltransferase 3A isoform b contributes to repressing E-cadherin through cooperation of DNA methylation and H3K27/H3K9 methylation in EMT-related metastasis of gastric cancer.
Cui H; Hu Y; Guo D; Zhang A; Gu Y; Zhang S; Zhao C; Gong P; Shen X; Li Y; Wu H; Wang L; Zhao Z; Fan H
Oncogene; 2018 Aug; 37(32):4358-4371. PubMed ID: 29717263
[TBL] [Abstract][Full Text] [Related]
36. The intronic long noncoding RNA ANRASSF1 recruits PRC2 to the RASSF1A promoter, reducing the expression of RASSF1A and increasing cell proliferation.
Beckedorff FC; Ayupe AC; Crocci-Souza R; Amaral MS; Nakaya HI; Soltys DT; Menck CF; Reis EM; Verjovski-Almeida S
PLoS Genet; 2013; 9(8):e1003705. PubMed ID: 23990798
[TBL] [Abstract][Full Text] [Related]
37. [Hypermethylation of Ras association domain family protein 1A, hypermethylated in cancer 1 and p73 genes in hepatocellular carcinoma].
Zhao ZH; Geng XP; Zhu LX; Li HM; Liew CT
Zhonghua Wai Ke Za Zhi; 2005 Dec; 43(23):1528-32. PubMed ID: 16412291
[TBL] [Abstract][Full Text] [Related]
38. Frequent hypermethylation of the RASSF1A gene in prostate cancer.
Liu L; Yoon JH; Dammann R; Pfeifer GP
Oncogene; 2002 Oct; 21(44):6835-40. PubMed ID: 12360410
[TBL] [Abstract][Full Text] [Related]
39. Aberrant Hypermethylation-Mediated Suppression of PYCARD Is Extremely Frequent in Prostate Cancer with Gleason Score ≥ 7.
Miyauchi T; Takahashi M; Mitsuzuka K; Saiki Y; Okubo T; Vertino PM; Goto A; Arai Y; Horii A; Fukushige S
Dis Markers; 2021; 2021():8858905. PubMed ID: 33628338
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic Regulation of CDH1 Is Altered after HOXB7-Silencing in MDA-MB-468 Triple-Negative Breast Cancer Cells.
Paço A; Leitão-Castro J; Freitas R
Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34680970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
